Comments on: India’s Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate

By: India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue | Intellectual Property Watch

Mon, 04 Mar 2013 19:59:20 +0000

[...] In an emailed statement to Intellectual Property Watch in May 2012, a Bayer spokesperson had said, “We strongly disagree with the conclusions of the Patent Controller of India and have appealed his order on May 4th 2012 with the Intellectual Property Appellate Board. We will rigorously continue to defend our intellectual property rights which are a prerequisite for bringing innovative medicines to patients” (IPW, Public Health, 20 May 2012). [...]

By: SoicalPost » Blog Archive » Generics Drive Down Drug Prices In India, TPP Trying To Stop That

Fri, 25 May 2012 12:04:54 +0000

[...] in India, where a compulsory license for Bayer’s Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back: ch_client = "joshuacompgeek"; ch_width = 468; ch_height = 180; ch_type = "mpu"; ch_sid = [...]

By: Generics Drive Down Drug Prices In India, TPP Trying To Stop That

Generics Drive Down Drug Prices In India, TPP Trying To Stop That — Thu, 24 May 2012 09:30:14 +0000

[...] Back in March, we wrote about an important development in India, where a compulsory license for Bayer’s Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back: [...]

By: Generics Drive Down Drug Prices In India, TPP Trying To Stop That | Techdirt

Thu, 24 May 2012 04:11:18 +0000

[...] development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back: in its 37-page appeal to the Intellectual Property Appellate Board, Bayer has "demanded the [...]

By: Generics Drive Down Drug Prices In India, TPP Trying To Stop That | Share Blog

Thu, 24 May 2012 03:21:04 +0000

[...] Back in March, we wrote about an important development in India, where a compulsory license for Bayer’s Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back: [...]

By: India’s War on Drugs — Expert Support NJ

India’s War on Drugs — Expert Support NJ — Tue, 22 May 2012 13:34:41 +0000

[...] Bayer, there would be no cheaper alternatives because they have fiercely fought against India’s generic drug distributors from obtaining patents for pharmaceuticals that treat cancer. Although Bayer initially lost their [...]

By: India’s Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate | Don't trade our lives away

Mon, 21 May 2012 11:51:43 +0000

[...] Source: Intellectual Property Watch [...]

By: GEIPER: IP Buzz (May 21, 2012) | Geipedia

GEIPER: IP Buzz (May 21, 2012) | Geipedia — Mon, 21 May 2012 04:37:41 +0000

[...] LINK [...]